US·Bill·118th Congress

S 1544

Died in committee

Facilitating Innovative Nuclear Diagnostics Act of 2023

Introduced 2023-05-10Last action 2023-05-10 — Read twice and referred to the Committee on Finance.Committee Senate Committee on Finance

Sponsor

Sen. Blackburn, Marsha [R-TN]R

Cosponsors (7)

Baldwin, Tammy(D-WI)Capito, Shelley Moore(R-WV)Collins, Susan M.(R-ME)Duckworth, Tammy(D-IL)Hassan, Margaret Wood(D-NH)Hyde-Smith, Cindy(R-MS)Shaheen, Jeanne(D-NH)

⚫

Died in committee

The 118th Congress ended on 2025-01-03. This bill was in committee when the session adjourned and did not advance to enactment.

Legislative Progress

✓

Introduced

✗

In Committee

Passed Chamber

Enacted / Signed

Action History

Read twice and referred to the Committee on Finance.

2023-05-10 · Senate

Introduced in Senate

2023-05-10 · Library of Congress

Summary

Facilitating Innovative Nuclear Diagnostics Act of 2023

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Full Bill Text

https://www.congress.gov/bill/118th-congress/s/1544

View full text →